A R Rachlis

Summary

Affiliation: University of Toronto
Country: Canada

Publications

  1. pmc Regional differences in rates of HIV-1 viral load monitoring in Canada: Insights and implications for antiretroviral care in high income countries
    Janet M Raboud
    Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
    BMC Infect Dis 10:40. 2010
  2. pmc CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation?
    Keri N Althoff
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD, 21205, USA
    AIDS Res Ther 7:45. 2010
  3. ncbi request reprint Safety, tolerability, and efficacy of darunavir (TMC114) with low-dose ritonavir in treatment-experienced, hepatitis B or C co-infected patients in POWER 1 and 3
    Anita Rachlis
    Division of Infectious Disease, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada
    HIV Clin Trials 8:213-20. 2007
  4. ncbi request reprint Effectiveness of step-wise intervention plan for managing nelfinavir-associated diarrhea: a pilot study
    Anita Rachlis
    Sunnybrook and Women s College Health Sciences Centre, University of Toronto, Ontario, Canada
    HIV Clin Trials 6:203-12. 2005
  5. ncbi request reprint Neurologic manifestations of HIV infection. Using imaging studies and antiviral therapy effectively
    A R Rachlis
    Department of Medicine, Sunnybrook Health Science Centre, University of Toronto Faculty of Medicine, Ontario, Canada
    Postgrad Med 103:147-50, 153-61. 1998
  6. ncbi request reprint Randomized controlled trial of once-daily tenofovir, lamivudine, and lopinavir/ritonavir versus remaining on the same regimen in virologically suppressed HIV-infected patients on their first PI-containing HAART regimen
    Mona R Loutfy
    Department of Medicine, University of Toronto, Toronto, Canada
    HIV Clin Trials 8:259-68. 2007
  7. ncbi request reprint Symptomatic primary HIV infection or risk experiences? Circumstances surrounding HIV testing and diagnosis among recent seroconverters
    Ann N Burchell
    HIV Social, Behavioural and Epidemiological Studies Unit, Department of Public Health Sciences, University of Toronto, Toronto, Ontario, Canada
    Int J STD AIDS 14:601-8. 2003
  8. ncbi request reprint Long-term follow-up of a cohort of HIV-infected patients who discontinued maintenance therapy for cytomegalovirus retinitis
    Sharon L Walmsley
    Department of Medicine, Toronto Hospital, University Health Network, University of Toronto, Canada
    HIV Clin Trials 7:1-9. 2006
  9. ncbi request reprint Nonfinancial factors associated with decreased plasma viral load testing in Ontario, Canada
    Janet M Raboud
    Division of Infectious Diseases, University Health Network, University of Toronto, Ontario, Canada
    J Acquir Immune Defic Syndr 39:327-32. 2005
  10. doi request reprint HIV postexposure prophylaxis use among Ontario female adolescent sexual assault victims: a prospective analysis
    Janice Du Mont
    Women s College Research Institute, Women s College Hospital, Toronto, Ontario, Canada
    Sex Transm Dis 35:973-8. 2008

Collaborators

Detail Information

Publications19

  1. pmc Regional differences in rates of HIV-1 viral load monitoring in Canada: Insights and implications for antiretroviral care in high income countries
    Janet M Raboud
    Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
    BMC Infect Dis 10:40. 2010
    ....
  2. pmc CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation?
    Keri N Althoff
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD, 21205, USA
    AIDS Res Ther 7:45. 2010
    ..10%, respectively). Due to the increasing proportion, consistently lower CD4 counts, and more advanced HIV disease in adults ≥50-year-old at first presentation for HIV care, renewed HIV testing efforts are needed...
  3. ncbi request reprint Safety, tolerability, and efficacy of darunavir (TMC114) with low-dose ritonavir in treatment-experienced, hepatitis B or C co-infected patients in POWER 1 and 3
    Anita Rachlis
    Division of Infectious Disease, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada
    HIV Clin Trials 8:213-20. 2007
    ..This subanalysis examines the safety and efficacy of darunavir with low-dose ritonavir (DRV/r) in hepatitis B or C virus (HBV or HCV) co-infected patients in POWER 1 and 3 trials...
  4. ncbi request reprint Effectiveness of step-wise intervention plan for managing nelfinavir-associated diarrhea: a pilot study
    Anita Rachlis
    Sunnybrook and Women s College Health Sciences Centre, University of Toronto, Ontario, Canada
    HIV Clin Trials 6:203-12. 2005
    ..Pilot study to evaluate the effectiveness of a step-wise diarrhea management strategy for nelfinavir-associated diarrhea...
  5. ncbi request reprint Neurologic manifestations of HIV infection. Using imaging studies and antiviral therapy effectively
    A R Rachlis
    Department of Medicine, Sunnybrook Health Science Centre, University of Toronto Faculty of Medicine, Ontario, Canada
    Postgrad Med 103:147-50, 153-61. 1998
    ..Even the antiviral drugs used to treat HIV infection can induce neurologic manifestations. Dr Rachlis discusses several of these manifestations and their management...
  6. ncbi request reprint Randomized controlled trial of once-daily tenofovir, lamivudine, and lopinavir/ritonavir versus remaining on the same regimen in virologically suppressed HIV-infected patients on their first PI-containing HAART regimen
    Mona R Loutfy
    Department of Medicine, University of Toronto, Toronto, Canada
    HIV Clin Trials 8:259-68. 2007
    ....
  7. ncbi request reprint Symptomatic primary HIV infection or risk experiences? Circumstances surrounding HIV testing and diagnosis among recent seroconverters
    Ann N Burchell
    HIV Social, Behavioural and Epidemiological Studies Unit, Department of Public Health Sciences, University of Toronto, Toronto, Ontario, Canada
    Int J STD AIDS 14:601-8. 2003
    ..5). SPHI plays a significant role in HIV testing and subsequent early diagnosis in this population. More seroconversions could be diagnosed with better patient and physician awareness of its symptoms...
  8. ncbi request reprint Long-term follow-up of a cohort of HIV-infected patients who discontinued maintenance therapy for cytomegalovirus retinitis
    Sharon L Walmsley
    Department of Medicine, Toronto Hospital, University Health Network, University of Toronto, Canada
    HIV Clin Trials 7:1-9. 2006
    ..To determine the long-term safety of discontinuation of maintenance therapy for cytomegalovirus retinitis (CMVR) and to identify predictors for relapse...
  9. ncbi request reprint Nonfinancial factors associated with decreased plasma viral load testing in Ontario, Canada
    Janet M Raboud
    Division of Infectious Diseases, University Health Network, University of Toronto, Ontario, Canada
    J Acquir Immune Defic Syndr 39:327-32. 2005
    ..To examine whether individual characteristics were associated with differential use of viral load testing when testing is available without charge to all HIV-positive patients with provincial health insurance...
  10. doi request reprint HIV postexposure prophylaxis use among Ontario female adolescent sexual assault victims: a prospective analysis
    Janice Du Mont
    Women s College Research Institute, Women s College Hospital, Toronto, Ontario, Canada
    Sex Transm Dis 35:973-8. 2008
    ..This study examined the use of HIV postexposure prophylaxis (PEP) among sexually assaulted adolescent females...
  11. ncbi request reprint Prospective cohort study of HIV post-exposure prophylaxis for sexual assault survivors
    Mona Rafik Loutfy
    Department of Medicine, University of Toronto, Ontario, Canada
    Antivir Ther 13:87-95. 2008
    ..There is a lack of standardized programs for HIV counselling and post-exposure prophylaxis (PEP) in the setting of sexual assault...
  12. ncbi request reprint 'Buffalo-hump' dermatitis: a hat trick of antiretroviral side-effects
    John R Sullivan
    Division of Clinical Pharmacology, Sunnybrook and Woman s College Health Sciences Center, University of Toronto Medical School, Ontario, Canada
    Contact Dermatitis 48:169-70. 2003
  13. ncbi request reprint Severe acute respiratory syndrome and the delivery of continuing medical education: case study from Toronto
    Dave Davis
    Continuing Education, University of Toronto, Ontario
    J Contin Educ Health Prof 24:76-81. 2004
    ....
  14. pmc Human papillomavirus type 16 viral load is higher in human immunodeficiency virus-seropositive women with high-grade squamous intraepithelial lesions than in those with normal cytology smears
    Jonas Lefevre
    Laboratoire de Virologie Moleculaire, Centre de Recherche du Centre Hospitalier de l Université de Montréal and Département de Microbiologie et Immunologie, Universite de Montreal, Montreal, Quebec, Canada
    J Clin Microbiol 42:2212-5. 2004
    ..002). HPV-16 viral load was 81-fold higher in women with cervical smears suggestive of high-grade lesions (median, 4,425,883 copies/ micro g of DNA) than in women with normal smears (median, 54,576), controlling for age (P = 0.006)...
  15. ncbi request reprint High levels of HPV-16 DNA are associated with high-grade cervical lesions in women at risk or infected with HIV
    Julie Fontaine
    Laboratoire de Virologie Moleculaire, Centre de recherche du Centre Hospitalier de l Universite de Montreal, Montreal, Quebec, Canada
    AIDS 19:785-94. 2005
    ..To examine associations between levels of episomal and integrated human papillomavirus (HPV) 16 DNA and the grade of cervical disease...
  16. ncbi request reprint Clinical impact of double protease inhibitor boosting with lopinavir/ritonavir and amprenavir as part of salvage antiretroviral therapy
    Mona Loutfy
    Immune Deficiency Treatment Centre, Montreal General Hospital, McGill University, Montreal, Quebec, Canada
    HIV Clin Trials 4:301-10. 2003
    ..This observational cohort study assessed the virologic impact of the addition of APV to a salvage ARV regimen, which also contains LPV/r, compared to a regimen containing LPV/r alone...
  17. ncbi request reprint Impact of acid-suppressive therapy on virologic response to atazanavir-based regimens in antiretroviral-experienced patients: a case series
    Tony Antoniou
    J Acquir Immune Defic Syndr 39:126-8. 2005
  18. doi request reprint Influence of human papillomavirus type 16 (HPV-16) E2 polymorphism on quantification of HPV-16 episomal and integrated DNA in cervicovaginal lavages from women with cervical intraepithelial neoplasia
    Naoufel Azizi
    Laboratoire de Virologie Moleculaire, Centre de recherche du Centre Hospitalier de l Universite de Montreal, Montreal, Quebec, Canada
    J Gen Virol 89:1716-28. 2008
    ..24) or CIN-1 (5 of 14, P=0.50). HPV-16 E2 polymorphism was a significant factor that influenced measures of HPV-16 integrated viral load...
  19. ncbi request reprint Efficacy and tolerability of long-term efavirenz plus nucleoside reverse transcriptase inhibitors for HIV-1 infection
    Karen Tashima
    Miriam Hospital, Providence, Rhode Island 02906, USA
    AIDS 22:275-9. 2008
    ..To compare the long-term efficacy and tolerability of two efavirenz-containing regimens with those of an indinavir-containing regimen in the initial use of HAART...